Literature DB >> 15147542

Characteristics of patients with staghorn calculi in our experience.

Keigo Akagashi1, Hitoshi Tanda, Shuji Kato, Shigeki Ohnishi, Hisao Nakajima, Akihito Nanbu, Toshikazu Nitta, Mikio Koroku, Yoshikazu Sato, Tatsuo Hanzawa.   

Abstract

PURPOSE: To elucidate the factors contributing to staghorn stone formation in patients.
MATERIALS AND METHODS: The records of 82 patients (44 men and 38 women) with complete staghorn calculi were reviewed retrospectively for clinical presentation, metabolic disturbances and anatomical abnormalities.
RESULTS: There were 79 unilateral and three bilateral cases. The patient performance of the activities of daily life was assessed with the modified Rankin scale (MRS) and it was found that 69 patients were functionally independent (84.1%, MRS 0-1) and 10 patients had a severe disability (12.2%, MRS 4-5). Seven patients had chronic indwelling catheters (8.5%). A positive urine culture was found in 24.4% of patients. Analysis of stone composition revealed magnesium ammonium phosphate and mixed calcium oxalate-phosphate were the most frequently identified types of stone (32.1% and 22.2%, respectively). Urinary pH was low in patients with uric acid stones (mean 5.4). Hyperuricemia, cystinuria and hypercalciuria were found in 14.6%, 2.4% and 37.8%, respectively. Hypercalciuria was found more frequently in calcium-stone cases. Eleven patients (13.4%) showed structural abnormalities of the kidney.
CONCLUSIONS: Our data show that the patients with severe disability, urinary tract infection and hypercalciuria could be recognized more frequently in staghorn calculi compared with common urolithiasis. However, in Western countries, the frequency of both urinary tract infection and struvite stones is much higher than in our data. Other Japanese authors have also reported the low frequency of struvite stones in staghorn calculi, suggesting that various factors other than urinary tract infection possibly contribute to the formation of staghorn calculi in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147542     DOI: 10.1111/j.1442-2042.2004.00800.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.

Authors:  S Proietti; A Giannantoni; L G Luciani; G Sortino; P Graziotti; G Giusti
Journal:  Urolithiasis       Date:  2014-06-28       Impact factor: 3.436

Review 2.  Renal struvite stones--pathogenesis, microbiology, and management strategies.

Authors:  Ryan Flannigan; Wai Ho Choy; Ben Chew; Dirk Lange
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.